Brief: Oragenics Announces Strategic Partnership With Receptor.AI To Accelerate Pipeline Development
07/10/2025 13:45
Oct 7 (Reuters) - Oragenics Inc OGEN.A: ORAGENICS ANNOUNCES STRATEGIC PARTNERSHIP WITH RECEPTOR.AI TO ACCELERATE PIPELINE DEVELOPMENT ORAGENICS INC - TO ADVANCE ONP-002 IN PHASE IIA TRIALS Q4 2025 Source text: ID:nBwt2W2ka Further company coverage: OGEN.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing